Helicid Max (Omeprazole)

Helicid Max, containing omeprazole, is indicated for several acid‑related gastrointestinal disorders.

• Gastro‑esophageal reflux disease (GERD) to relieve heartburn and regurgitation.
• Peptic ulcer disease, including gastric and duodenal ulcers, to promote healing.
• Part of combination therapy for Helicobacter pylori eradication.
• Management of Zollinger‑Ellison syndrome, a condition of excessive gastric acid secretion.
• Prevention of ulcer recurrence in patients at risk from non‑steroidal anti‑inflammatory drugs (NSAIDs).
• Prophylaxis of stress‑related mucosal damage in critically ill patients.

The safety profile of Helicid Max reflects the typical adverse events reported for omeprazole.

Common

• Headache.
• Diarrhea.
• Nausea.
• Abdominal pain.
• Flatulence.
• Constipation.

Serious

• Severe allergic reactions such as Stevens‑Johnson syndrome.
• Clostridioides difficile infection.
• Low magnesium levels (hypomagnesemia).
• Elevations in liver enzymes.
• Increased risk of bone fractures with long‑term use.

Before initiating Helicid Max, healthcare professionals should evaluate several precautionary factors.

• Assess renal or hepatic impairment, as dose adjustment may be needed.
• Review history of allergic reactions to PPIs or similar compounds.
• Consider potential risk of osteoporosis with prolonged therapy, especially in older adults.
• Monitor magnesium levels during long‑term use.
• Use cautiously in patients with known infections such as C. difficile.
• Evaluate pregnancy and lactation status, as safety data are limited.

Helicid Max may interact with other medicines, influencing their effectiveness or safety.

Avoid

• Co‑administration with atazanavir or nelfinavir, which require an acidic environment for absorption.
• Use with clopidogrel, as omeprazole can reduce its antiplatelet activity.
• Concomitant use with high‑dose methotrexate, which may increase toxicity.

Use with caution

• Warfarin, may enhance anticoagulant effect; monitor INR.
• Digoxin, may increase serum levels; monitor therapeutic range.
• Certain HIV protease inhibitors (e.g., ritonavir) may have altered plasma concentrations.
• Antifungal agents such as ketoconazole, which need acidic pH for optimal absorption.